ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in ENDRA Life Sciences Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 4
- −7 vs. Q3 2024
- Shares held
- 115
- −168.7K (−99.9%) vs. Q3 2024
- Total value
- $720
- −$32.2K (−97.8%) vs. Q3 2024
- New holders
- 1
- 0 more added
- Sold out
- 8
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 95 | $595 | 0.00% | +95 | New |
| Morgan Stanley | 13 | $81 | 0.00% | −2,602−99.5% | Reduced |
| Bank of America Corp | 4 | $25 | 0.00% | −7−63.6% | Reduced |
| Danske Bank A/S | 3 | $19 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −80,516−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,211−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −16,326−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,175−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,213−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,197−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,848−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −691−100.0% | Sold out |